Date published: 2025-11-6

00800 4573 8000

SCBT Portrait Logo
Seach Input

apoA-I Inhibidores

ApoA-I inhibitors are compounds that belong to a chemical class designed to interact with and modulate the activity of apolipoprotein A-I (apoA-I). ApoA-I is a protein that plays a crucial role in lipid metabolism and transport, particularly in the formation of high-density lipoproteins (HDL) or good cholesterol. These inhibitors are developed to target the binding sites or interactions of apoA-I with lipids and other proteins involved in lipoprotein assembly and function.

By targeting apoA-I, these inhibitors provide a means to explore the intricate processes of HDL formation and cholesterol transport within the body. ApoA-I inhibitors enable researchers to investigate how modulating apoA-I's interactions with lipids influences the assembly, stability, and functionality of HDL particles. Additionally, studying the effects of apoA-I inhibitors may offer insights into their roles in cardiovascular health, lipid disorders, and other related conditions. Overall, apoA-I inhibitors serve as valuable tools for unraveling the complex interplay of proteins and lipids in maintaining lipid homeostasis and overall metabolic balance.

VER TAMBIÉN ....

Nombre del productoNÚMERO DE CAS #Número de catálogoCantidadPrecioMENCIONESClasificación

Anacetrapib

875446-37-0sc-364404
sc-364404A
10 mg
50 mg
¥6938.00
¥20138.00
(0)

Inhibidor de CETP que modula los niveles de ApoA-I y el metabolismo lipídico relacionado.

Dalcetrapib

211513-37-0sc-364479
sc-364479A
10 mg
50 mg
¥8123.00
¥21436.00
(0)

Inhibidor de CETP que afecta a los niveles de ApoA-I y al metabolismo lipídico.

RVX 208

1044870-39-4sc-472700
10 mg
¥3836.00
(0)

Aumenta la transcripción de ApoA-I mediante la inhibición del bromodominio BET.